High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Jeong Hwan ShinChulhun Ludgerus Chang

Abstract

The aims of this study were to investigate the prevalence of qnrA, qnrB, and qnrS determinants and their molecular characteristics in ciprofloxacin-resistant isolates of Escherichia coli and Klebsiella pneumoniae from urinary tract infections (UTI) in Korea. A total of 202 nonduplicated clinical isolates of ciprofloxacin-resistant E. coli (n = 143) and K. pneumoniae (n = 59) were collected between July 2005 and August 2006. The qnr determinant screening was carried out by PCR amplification of qnrA, qnrB, and qnrS, and all positive results were confirmed by direct sequencing of the PCR products. For qnr-positive strains and their conjugants, antimicrobial susceptibility tests and pulsed-field gel electrophoresis (PFGE) were performed. The qnrB gene was detected in 41 of the 202 isolates. Among 33 of 59 (55.9%) K. pneumoniae isolates showing qnrB, 29 isolates contained the qnrB4 gene, 3 isolates had the qnrB2 gene, and 1 isolate had the qnrB6 gene. All 8 (5.6%) of the qnrB-positive isolates among the 143 E. coli strains possessed the qnrB4 gene. The minimum inhibitory concentrations (MICs) of ciprofloxacin for the transconjugants were 0.03-2 mug/ml, representing an increase of 4- to 256-fold relative to the recipient, E. coli J53...Continue Reading

References

Oct 28, 1993·The New England Journal of Medicine·W E Stamm, T M Hooton
Mar 31, 1998·Lancet·L Martínez-MartínezG A Jacoby
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·John H Tran, George A Jacoby
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy·Luis Martínez-MartínezGeorge A Jacoby
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Minggui WangDavid C Hooper
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Hedi MammeriPatrice Nordmann
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·John H TranDavid C Hooper
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Mami HataKenji Sakae
May 27, 2005·Antimicrobial Agents and Chemotherapy·Jin-Yong JeongYang Soo Kim
Jun 9, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George A Jacoby
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·John H TranDavid C Hooper
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George A JacobyDavid C Hooper
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathryn GayDavid C Hooper

❮ Previous
Next ❯

Citations

Jan 26, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S A DunhamA A Miller
Aug 13, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Haeng Soon JeongJeong Nyeo Lee
Aug 13, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Haeng Soon JeongJeong Nyeo Lee
Feb 2, 2011·Antimicrobial Agents and Chemotherapy·Noe ReyesCorwin F Kostrub
Oct 14, 2009·Clinical Microbiology Reviews·Jacob StrahilevitzAri Robicsek
Jan 21, 2012·BMC Research Notes·Pankaj BaralBasudha Shrestha
May 7, 2009·Future Microbiology·Gayatri Vedantam
Oct 5, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·José Manuel Rodríguez-MartínezAlvaro Pascual
Dec 12, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Rachel M GreenblattEbbing Lautenbach
Aug 12, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Chuanming ZhangLiping Zhang
Oct 26, 2018·The Journal of Antimicrobial Chemotherapy·Boas C L van der PuttenConstance Schultsz
Jul 3, 2009·The Korean journal of laboratory medicine·Yongjung ParkKyungwon Lee
Jan 15, 2015·Microbiology Spectrum·George A JacobyDavid C Hooper
Jul 6, 2021·Saudi Journal of Biological Sciences·Kawther AabedSaleha Alzahrani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.